03 · What You Need to Know
Eligibility and Enrollment Are Different Decisions
Meeting eligibility criteria does not always guarantee a place
Eligibility criteria define who may be considered for a study. They do not necessarily create an entitlement to enrollment.
A study may have 500 eligible volunteers but need only 100 participants. Researchers may use purposive sampling, stratified sampling, random selection, quotas, sequential enrollment, matched sampling, or another approved selection procedure.
In clinical research, eligibility may also remain provisional until screening tests, records, investigator review, or other protocol requirements are completed.
Researchers should therefore avoid language such as “You have been accepted into the study” when the person has merely passed an initial eligibility screen.
Eligible
The person appears to meet the relevant inclusion and exclusion criteria at the applicable stage of screening.
Selected or enrolled
The person has proceeded through the study's approved selection and enrollment process and has been included as a participant.
Recruitment materials should avoid promising enrollment
FDA guidance describes recruitment advertising as part of the subject-selection and informed-consent process and permits summary eligibility criteria to help prospective participants determine whether they may be interested. It does not treat an advertisement's eligibility description as a guarantee of enrollment.
A recruitment message saying “Adults aged 18 to 30 may be eligible” is therefore preferable to language implying that everyone satisfying one visible criterion will automatically enter the study.
This matters particularly when screening requires several stages.
Preliminary eligibility is not always final eligibility
A person may pass an online screener and later fail a clinical screening test. Someone may self-report an eligible age and diagnosis but records may show that another exclusion criterion applies.
FDA guidance on clinical-study screening distinguishes discussion of possible study entry from research-specific screening procedures and requires informed consent before clinical procedures performed solely to determine research eligibility. If screening shows that the prospective participant is eligible, the approved consent procedures for the study then follow.
The broader lesson is that “eligible” may refer to different stages. Researchers should communicate which stage has actually been completed.
Sometimes eligible people are deliberately not selected
Not every study enrolls all eligible volunteers.
Consider a qualitative study seeking variation across career stage. Fifty eligible participants volunteer, but the approved sampling plan calls for 20 interviews distributed across predefined groups.
Some people may meet every eligibility criterion yet not be selected because the relevant sampling category is already sufficiently represented.
Another study may randomly select participants from a larger eligible pool. In that case, nonselection does not indicate anything unfavorable about the person.
Researchers can explain the general selection process when appropriate and consistent with the approved materials without disclosing information about other volunteers.
Do not invent a reason to make the answer feel personal
A prospective participant may naturally ask:
“Why me?”
Sometimes there is no individualized answer.
If 200 eligible people volunteered for 50 places and selection was random, the accurate explanation is that enrollment was limited and selection followed the approved procedure.
Researchers should not invent:
“We found participants who were a better fit.”
That statement may imply the person was comparatively deficient when the study made no such judgment.
Likewise, saying “You weren't suitable” can be misleading when the person was suitable but simply not selected.
Selection explanations should not reveal other people's information
Suppose a person asks why another colleague was selected while they were not.
The researcher's explanation should not disclose the colleague's screening responses, health status, demographic information, or other private information.
Researchers can explain the selection process at an appropriate general level without comparing identifiable prospective participants.
“The study was seeking participants across several predefined groups and enrollment in some groups filled earlier” may be sufficient where accurate.
“Your colleague was selected because she has condition X and you do not” may disclose information that is not the questioner's business.
Screening information requires its own privacy plan
People who are never enrolled may still have provided researchers with personal information.
FDA recruitment guidance specifically asks IRBs to consider what happens to personal information collected from prospective participants who prove ineligible, including whether names are retained for future studies and how records are destroyed.
The revised Common Rule also contains specific provisions allowing an IRB to approve certain screening, recruitment, or eligibility activities involving information or biospecimens without prospective informed consent under defined circumstances.
The important practical point is that “not enrolled” does not mean “no research-privacy issue.”
Researchers should follow the approved plan for retaining, deleting, coding, or otherwise handling screening data.
Research screening results are not automatically clinical diagnoses
A screening procedure may generate information that interests or worries the prospective participant.
Researchers should be careful about what those results mean.
A research screening instrument may not be validated or intended for diagnosis. A questionnaire score may indicate eligibility without establishing a medical or psychological condition. Laboratory or genetic screening may have additional legal, clinical, or counseling implications.
FDA notes that certain clinical screening tests can carry specific state-law requirements concerning disclosure, access, reporting, employment, or insurance implications.
Researchers should therefore communicate screening results according to the approved protocol and applicable professional and legal requirements rather than improvising clinical interpretations.
Being “not selected” is different from being “screen failed”
These outcomes should not be casually conflated.
| Outcome |
Meaning |
Typical communication issue |
| Ineligible |
The person does not meet one or more applicable study criteria. |
Whether and how the reason should be communicated under the approved screening process. |
| Eligible but not selected |
The person qualifies but is not chosen under the approved sampling or enrollment process. |
Clarifying that eligibility did not guarantee enrollment. |
| Enrollment closed |
The study has reached its recruitment limit or stopped recruitment. |
Explaining that nonenrollment does not necessarily reflect eligibility. |
| Eligibility not fully determined |
Screening ended before a final eligibility determination was completed. |
Avoiding an unsupported claim that the person was either eligible or ineligible. |
Precise language prevents unnecessary confusion and avoids attributing judgments the research process never made.
Selection procedures should follow the approved protocol
If a protocol states that all eligible participants will be enrolled sequentially until the target is reached, researchers should not later choose only their preferred eligible candidates because too many people volunteered.
Likewise, if selection is supposed to be random, convenience should not quietly replace random selection.
Changing the selection mechanism can affect scientific validity, fairness, and the composition of the sample. Depending on the governing framework, such a change may require ethics review or approval before implementation.
Researchers should not solve oversubscription by inventing an unapproved selection rule any more than they should solve under-recruitment by inventing an unapproved recruitment strategy.
Consider whether notification itself was promised
Some studies tell prospective participants that everyone will be notified of the screening outcome. Others state that only selected or eligible individuals will be contacted.
Researchers should follow what the approved recruitment and screening materials actually promise.
If hundreds of people submit an expression-of-interest form that explicitly says “Only selected candidates will be contacted,” individualized rejection messages may not be required unless another applicable policy says otherwise.
Conversely, if people undergo substantial screening procedures and are told they will receive an outcome, simply disappearing may be inconsistent with the approved process and basic expectations created by the study.
Watch Out
Do not use “not selected” as a convenient label when you have actually determined that someone is ineligible, and do not tell someone they are ineligible when the study merely had more eligible volunteers than available places. Those statements communicate different things about the person.
